Group 1 - Huawei officially launched the Enjoy 90 series on March 23, 2026, marking the comprehensive coverage of the HarmonyOS ecosystem from flagship to mass-market devices [1] - Meituan's delivery applications, Meituan Crowdsourcing and Meituan Rider, received significant upgrades, introducing the "indoor precise positioning and navigation" feature, which addresses delivery challenges in complex environments like shopping malls [1][2] Group 2 - The new indoor precise positioning and navigation feature effectively resolves long-standing delivery issues faced by riders, such as positioning drift and inaccurate floor identification, significantly improving delivery efficiency [2] - The feature boasts an average positioning accuracy of less than 10 meters and a floor recognition accuracy rate exceeding 95%, allowing riders to reduce unnecessary detours [2] - The Meituan Crowdsourcing and Meituan Rider apps, developed using the domestic programming language Cangjie, provide a smooth experience and have been optimized for the HarmonyOS, ensuring high performance and low power consumption [3] - The collaboration between Meituan and HarmonyOS aims to enhance delivery efficiency, operational convenience, and safety, continuously innovating to improve the user experience for riders [3]

智通财经APP获悉，瑞银发布研报称，恒基地产(00012)去年核心盈利61亿元，同比下跌38%，符合该行 预期。公司削减末期息至每股0.76港元，连同中期息每股0.5港元，全年共派息1.26港元，同比减少 30%，减幅大致符合市场预期。予恒地目标价30.5港元，评级为"中性"。另外，报告引述恒地管理层 指，预期在西半山"天御"项目入帐支持下，2026财年香港地区发展物业毛利率将回升至17%至19%(high teens)水平。 ...

Core Viewpoint - China National Pharmaceutical Group (国药控股) reported a slight decline in revenue for the fiscal year 2025, while net profit showed a modest increase, indicating mixed performance across its business segments [1] Financial Performance - The company achieved a revenue of RMB 575.168 billion, representing a year-on-year decrease of 1.6% [1] - Net profit attributable to shareholders was RMB 7.155 billion, reflecting a year-on-year increase of 1.5% [1] - Earnings per share were reported at RMB 2.29, with a proposed final dividend of RMB 0.69 per share [1] Business Segment Analysis - The pharmaceutical distribution segment accounted for 72.79% of total revenue, down 0.37 percentage points year-on-year [1] - The medical device distribution segment contributed 19.32% to revenue, showing a slight decline of 0.09 percentage points [1] - The retail pharmaceutical segment's revenue share increased to 6.42%, up 0.50 percentage points year-on-year [1] Market Expectations - Citigroup's report indicated that the management expects the pharmaceutical distribution business sales to remain flat year-on-year, while medical device distribution and retail businesses are anticipated to recover and achieve positive growth [1] - Citigroup has revised down its revenue forecasts for the company by 3% and 4% for the next two years, reflecting the latest guidance from management [1] - The earnings per share forecast has been adjusted down by 5% for both years, with the target price lowered from HKD 23 to HKD 22.8, while maintaining a "Buy" rating [1]

Core Viewpoint - 招银国际 has raised the target price for AIA Group (01299) by 25.8%, from HKD 89 to HKD 112, maintaining a "Buy" rating [1] Group 1: Business Performance - AIA's new business value (VONB) for 2025 reached USD 5.516 billion, reflecting a year-on-year increase of 15% (at constant exchange rates) and 17% (at actual exchange rates) [2] - The group’s operating profit after tax (OPAT) increased by 8% (at constant exchange rates) to USD 7.14 billion, with earnings per share rising by 12%, aligning with the company's target of 9-11% compound annual growth for earnings per share from 2023 to 2026 [3] - The group’s new business value margin improved to 58.5%, up 3.6 percentage points year-on-year, driven by product launches and medical insurance repricing in Hong Kong (+3.0 percentage points) and Thailand (+11.4 percentage points) [2] Group 2: Shareholder Returns - AIA announced a share buyback plan of USD 1.7 billion, exceeding expectations, alongside a dividend of USD 2.6 billion, representing a 10% year-on-year increase, leading to a total shareholder return of USD 4.3 billion in 2026 [2] - The company’s free surplus remained strong at USD 6.8 billion, with a year-on-year growth of 11% per share, while net free surplus exceeded USD 4.4 billion, growing by 9% year-on-year [3] - The capital adequacy ratio for shareholders stood at 221%, comfortably above the target of over 200% [3] Group 3: Future Outlook - AIA's new business value in China is expected to grow by over 20% in January-February 2026, while growth in Thailand is anticipated to slow due to a high base effect from the first quarter of 2025 [1] - The target price adjustment is based on a value assessment method, with a slight upward revision of 3% for OPAT and VONB growth expectations for 2026 and 2027 [1]

Core Viewpoint - Morgan Stanley's report indicates that AIA Group (01299) had solid performance last year, with share buybacks exceeding expectations and management's confidence in growth quality, leading to adjustments in financial forecasts [1] Group 1: Financial Forecast Adjustments - The cash generation forecast for existing life insurance policies for 2026 to 2028 has been raised to between $7.7 billion and $9.6 billion, reflecting improved capital efficiency prospects [1] - Core earnings and Contractual Service Margin (CSM) balance forecasts have been slightly increased, indicating a continued trend of profit growth [1] - The target price for AIA has been adjusted from HKD 115 to HKD 112, while maintaining an "Overweight" rating [1] Group 2: New Business Value and Growth - The new business value to new business investment ratio improved from 3 times and 3.1 times in 2023/2024 to 3.8 times last year, reflecting future cash generation capabilities [1] - New business value is projected to be $6.2 billion and $7.4 billion for 2026 and 2027, respectively, surpassing market expectations of $6.3 billion and $7.2 billion [2] - CSM balance is expected to grow from $72 billion at the end of this year to $92 billion by the end of 2028, supporting strong compound effects on the balance sheet [1] Group 3: Share Buyback and Return Expectations - The group announced a share buyback plan of $1.7 billion for this year, with an estimated total shareholder return of about 4% over the next 12 months, providing downside protection [2] - However, no additional buybacks are anticipated after 2026 [2]

Core Viewpoint - Morgan Stanley's report indicates that AIA Group (01299) had solid performance last year, with a larger-than-expected buyback plan and management's confidence in growth quality leading to adjustments in financial forecasts [1] Group 1: Financial Forecast Adjustments - The cash generation forecast for existing life insurance policies for 2026 to 2028 has been raised to between $7.7 billion and $9.6 billion, reflecting improved capital efficiency prospects [1] - Core earnings and Contractual Service Margin (CSM) balance forecasts have been slightly increased, indicating a continued trend of profit growth [1] - The target price for AIA has been adjusted from HKD 115 to HKD 112, while maintaining an "Overweight" rating [1] Group 2: New Business Value and Growth - The new business value to new business investment ratio improved from 3 times and 3.1 times in 2023/2024 to 3.8 times last year, reflecting future cash generation capabilities [1] - New business value is projected to be $6.2 billion and $7.4 billion for 2026 and 2027, respectively, exceeding market expectations of $6.3 billion and $7.2 billion [2] - CSM balance is expected to grow from $72 billion at the end of this year to $92 billion by the end of 2028, supporting strong compound effects on the balance sheet [1] Group 3: Buyback and Shareholder Returns - The group announced a buyback budget of $1.7 billion for this year, with an estimated total shareholder return of about 4% over the next 12 months, providing downside protection [2] - However, no additional buybacks are anticipated after 2026 [2]

Core Viewpoint - JPMorgan has released a report indicating a positive outlook for Li Ning (02331), highlighting two key signals for recovery: regaining market share after a decline since 2022 and effective cost control [1] Group 1: Earnings Forecast - JPMorgan has raised its earnings forecast for Li Ning for 2026 to 2027 by 9% to 12% [1] - The company is expected to achieve a sales growth of 8% and a profit growth of 7% in 2026 [1] - The target price for Li Ning has been increased from HKD 14.6 to HKD 25.6, with the rating upgraded from "Underweight" to "Overweight" [1] Group 2: Positive Signals - Li Ning has shown both positive signals mentioned, with a projected 13% year-on-year profit growth in the second half of 2025, exceeding JPMorgan's forecast by 17% and market expectations by 28% [1] - The profit growth is attributed to cost optimization in direct retail channels and higher-than-expected government subsidies, which offset the rising costs of advertising and promotion [1] - The sales guidance for 2026 is positive, indicating a high single-digit growth, suggesting a potential end to the market share decline that has persisted since 2022 [1]

Core Viewpoint - The domestic leading automotive internet service platform "Autohome" has had multiple official accounts on social media platforms banned from being followed due to violations in comment section interactions [1] Group 1 - On January 23, customer service from relevant platforms stated that the reason for the ban on following accounts is typically due to violations in the comment section [1] - Earlier in January, "Autohome" was criticized by the Central Cyberspace Administration for irregular evaluation projects [1]

Core Viewpoint - Hang Lung Properties (00012) reported a slight increase in revenue for the fiscal year 2025, but a significant decrease in shareholder profit, reflecting challenges in the property market and the impact of previous land sales [1] Financial Performance - The company achieved revenue of HKD 25.741 billion, a year-on-year increase of 1.92% [1] - Shareholder profit amounted to HKD 5.653 billion, a decrease of 10.21% year-on-year [1] - Basic earnings per share were HKD 1.17, with a proposed final dividend of HKD 0.76 per share [1] Earnings Analysis - The decline in underlying profit was primarily due to last year's significant gains from government land acquisitions and the sale of a controlling stake in an investment property, which contributed approximately HKD 4.768 billion to profits [1] - In contrast, this year's land acquisition only contributed HKD 0.599 billion to profits [1] Market Outlook - Goldman Sachs reported that the lack of one-time significant gains from land acquisitions in 2024 led to a projected 38% year-on-year decline in underlying profit to HKD 6.1 billion, aligning with market expectations [1] - The firm views Hang Lung Properties as a beneficiary of the rising cycle in the Hong Kong residential market, anticipating a strong recovery in profits with a projected compound annual growth rate of over 20% from 2026 to 2028 [1] - The company holds a substantial land bank of 40.5 million square feet, which can be monetized or redeveloped in conjunction with adjacent plots for future development [1]

Core Viewpoint - Everbright Environment (00257.HK) experienced a significant increase in stock price, rising over 4% at one point and closing with a gain of 3.86% at HKD 5.37, with a trading volume of HKD 66.50 million [2] Company Summary - Everbright Environment's stock price showed strong performance on March 24, with a peak increase of over 4% [2] - The closing price was HKD 5.37, reflecting a 3.86% increase [2] - The total trading volume reached HKD 66.50 million [2]